Evidence map›Paper›PMID 41801018›Full record

ArticleEnvironmental science & technology2026

Prenatal Exposure to Mixtures of Nonpersistent Endocrine-Disrupting Chemicals and Angiogenic Biomarkers, Placental Function, and Fetal Growth.

Bethany Knox, Nuria Güil-Oumrait, Vishal Midya, Hana Vespalcová, Maria Dolores Gómez-Roig, Elisa Llurba, Sandra Márquez, Zoraida García Ruiz, Toni Galmes, Claire Philippat and 12 more

Abstract read
In one paragraph

Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Bethany KnoxISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.ORCID 0000-0001-5870-9344
Nuria Güil-OumraitISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.ORCID 0000-0003-4097-7038
Vishal MidyaDepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1091, New York, New York 10029, United States.ORCID 0000-0002-6643-5176
Hana VespalcováISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.ORCID 0000-0003-0404-3166
Maria Dolores Gómez-RoigBCNatal. Barcelona Center for Maternal Fetal and Neonatal Medicine (Hospital Sant Joan de Déu and Hospital Clínic), University of Barcelona, Institut de Recerca Sant Joan de Déu, Passeig Sant Joan de Déu 2, Barcelona 08950, Spain.
Elisa LlurbaHospital de La Santa Creu i Sant Pau, Department of Obstetrics and Gynaecology, Institut D'Investigació Biomèdica Sant Pau - IIB Sant Pau, Sant Antoni Maria Claret, 167, Barcelona 08025, Spain.
Sandra MárquezISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Zoraida García RuizPrimary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin Network (RICORS), RD21/0012/0003, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, Fuencarral-El Pardo, Madrid 28029, Spain.
Toni GalmesISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Claire PhilippatUniversity Grenoble Alpes, Inserm U-1209, CNRS-UMR-5309, Environmental Epidemiology Applied to Reproduction and Respiratory Health Team, Institute for Advanced Biosciences, Site Santé, Allée des Alpes, La Tronche, Grenoble 38700, France.ORCID 0000-0002-4959-6648
Amrit Kaur SakhiDepartment of Food Safety, Norwegian Institute of Public Health (NIPH), PO Box 222 Skøyen, Oslo N-0213, Norway.
Cathrine ThomsenDepartment of Food Safety, Norwegian Institute of Public Health (NIPH), PO Box 222 Skøyen, Oslo N-0213, Norway.
Jose UrquizaISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Maria Julia ZaniniHospital de La Santa Creu i Sant Pau, Department of Obstetrics and Gynaecology, Institut D'Investigació Biomèdica Sant Pau - IIB Sant Pau, Sant Antoni Maria Claret, 167, Barcelona 08025, Spain.
Payam DadvandISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Mireia GasconISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Ioar RivasISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Maria ForasterPHAGEX Research Group, Blanquerna School of Health Science, Universitat Ramon Llull, Barcelona, ES 08022, Spain.
Xavier BasagañaISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.ORCID 0000-0002-8457-1489
Jordi SunyerISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Mariona BustamanteISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.
Martine VrijheidISGlobal, C/Doctor Aiguader, 88, Barcelona 08003, Spain.ORCID 0000-0002-7090-1758

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to endocrine-disrupting chemicals (EDCs) during pregnancy may influence the placenta and fetal growth; however, evidence is scarce regarding EDC mixtures, newer chemicals, and the role of angiogenic biomarkers and fetoplacental hemodynamics. We aimed to examine the associations between nonpersistent EDC mixtures and fetal growth, fetoplacental hemodynamics, and angiogenic biomarkers. We included 734 pregnant participants from the Barcelona Life Study Cohort (BiSC), Spain (2018-2021). Metabolites of phthalates, DINCH, insecticides, polycyclic aromatic hydrocarbons, pesticides, flame retardants, and parent compounds of phenols and parabens were measured in pools of week-long maternal urine samples at 18 and 34 weeks' gestation. Penalized LASSO-type multigroup Bayesian Weighted Quantile Sum Regression estimated associations with fetal growth, fetoplacental hemodynamics, and angiogenic biomarkers. Birthweight z-score decreased with low-molecular-weight phthalate (LMWP) (β = -0.119; CrI -0.224, -0.008) mixtures and increased with organophosphate mixtures (β = 0.143; CrI 0.042, 0.245). LMWP exposure was also associated with altered hemodynamics and angiogenic biomarkers; angiogenic biomarkers mediated the relationship with birthweight z-score (ACME = -0.032; 95% CI -0.062, -0.009;

Indexed as

Endocrine DisruptorsFetal DevelopmentPlacentaBiomarkersFemaleHumansPhthalic AcidsPregnancyBiomarkersEndocrine DisruptorsPhthalic AcidsBayesianchemical mixturesenvironmental healthfetal growthplacenta

Identifiers

PMID41801018
PMCPMC13019680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.